TRAMETINIB
trametinib 500 microgram tablet, 30
TRAMETINIB (10385N)
10385N
Manner of administration:Oral
Restriction (Streamlined authority code: 17951)
Indication: Unresectable Stage III or Stage IV malignant melanoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 90 | # of repeats: 5 | DPMQ: $5,395.83 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||
